✓ Geverifieerd
Vertrouwensscore 98/100
Dr. Hariharan Kuhan
· London
👤 6 jaar ervaring
6,915+
Patients seen
6
Years in practice
9
Publications
1
Languages spoken
Over
Dr Hariharan Kuhan is the Co-Founder and Medical Director of Lucio Health, where he leads the development of personalised, data-driven approaches to cancer and metabolic health. His clinical background spans mainstream oncology, early-phase trials, and academic research, with a strong focus on integrating metabolic medicine into modern cancer care.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Hariharan Kuhan
Opleiding & training
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency
-
2020–2021 Fellowship · Subspecialty training
Carrière & aanstellingen
-
2020-09–2021-08 Junior consultant
Vergunningen & verzekering
Medische licenties
GB — Organización Médica Colegial de España (OMC)
Boardcertificeringen
European Board of
Beroepsaansprakelijkheidsverzekering:
Generali Healthcare · 4,000,000 EUR dekking · No claims on file
Uitgevoerde procedures
| Procedure | Code | Levenslang aantal |
|---|---|---|
| GP consultation | 99213 | 1,527 |
| Annual physical exam | 99395 | 2,361 |
| Vaccination administration | 90471 | 417 |
| Minor procedure (skin) | 17110 | 2,758 |
Diensten & prijzen
| Dienst | Duur | Modaliteit | Prijs |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Praktijk, team & in praktijk
Video's
Onderzoek & publicaties
h-index: 18 · i10: 9
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.1289/euroclin.2025.0 · PMID: 33124820 · geciteerd door 39
-
European registry analysis of outcomes
DOI: 10.6802/euroclin.2024.1 · PMID: 30650891 · geciteerd door 157
Uitgenodigde lezingen
- Practical updates in European Annual Congress () · Vienna · 2024 · invited
- Single-centre experience in National Society Meeting · London · 2023 · oral abstract
Onderscheidingen & lidmaatschappen
Onderscheidingen
- 🏆 Top-rated — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Lidmaatschappen
- WONCA Europe — Family Doctors — Member · Sinds 2021
- national college of family doctors — Member · Sinds 2021
- European Union of Medical Specialists (UEMS) — Member · Sinds 2021
Artikelen van deze arts
- Patient education Patient guide to
- Awareness When should you see a ?
Voor internationale patiënten
- Coördinator
- Patient liaison · hariharan.kuhan@euroclinics.example
- Geaccepteerde internationale verzekeringen
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Locatie
1 tagPatiëntbeoordelingen
26 geverifieerde recensies5.00
★★★★★
26 recensies
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Deel uw ervaring — help andere patiënten de juiste arts te vinden. Schrijf een recensie →
Recente recensies
-
★★★★★ ✓ Geverifieerd Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Geverifieerd Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Geverifieerd Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.